DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Adamkewicz JI, Schmitt C, Asikanius E. et al.
Factor VIII Inhibitor Testing Using a Validated Chromogenic Bethesda Assay (CBA) in HAVEN 1 (bh29884), a Phase 3 Trial of Emicizumab in Persons with Hemophilia A (PwHA) with Inhibitors.
Berlin, Germany: International Society on Thrombosis and Haemostasis; 2017
We do not assume any responsibility for the contents of the web pages of other providers.